Myelination in the central nervous system takes place predominantly during the postnatal development of humans and rodents by myelinating oligodendrocytes (OLs), which are differentiated from oligodendrocyte progenitor cells (OPCs). We recently reported that Sox2 is essential for developmental myelination in the murine brain and spinal cord. It is still controversial regarding the role of Sox2 in oligodendroglial lineage progression in the postnatal murine spinal cord. Analyses of a series of cell- and stage-specific Sox2 mutants reveal that Sox2 plays a biphasic role in regulating oligodendroglial lineage progression in the postnatal murine spinal cord. Sox2 controls the number of OPCs for subsequent differentiation through regulating their proliferation. In addition, Sox2 regulates the timing of OL differentiation and modulates the rate of oligodendrogenesis. Our experimental data prove that Sox2 is an intrinsic positive timer of oligodendroglial lineage progression and suggest that interventions affecting oligodendroglial Sox2 expression may be therapeutic for overcoming OPC differentiation arrest in dysmyelinating and demyelinating disorders.
Pubmed ID: 29623612 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets Mouse PDGF R alpha
View all literature mentionsThis monoclonal targets beta-actin
View all literature mentionsThis monoclonal targets Myelin Basic
View all literature mentionsThis monoclonal targets BrdU (3H579)
View all literature mentionsThis unknown targets Raised against peptide mapping to N-terminus of sox-10 of human origin
View all literature mentionsThis unknown targets CMG1
View all literature mentionsThis polyclonal targets NG2 Chondroitin Sulfate Proteoglycan
View all literature mentionsThis polyclonal targets GFP (Green Fluorescent Protein)
View all literature mentionsThis polyclonal targets TCF-4 (C-19)
View all literature mentionsThis polyclonal targets Human Olig2
View all literature mentionsThis polyclonal targets SOX2
View all literature mentionsMus musculus with name B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J from IMSR.
View all literature mentionsMus musculus with name B6.129P-Psen2tm1Bdes/J from IMSR.
View all literature mentionsMus musculus with name B6;CBA-Tg(Sox10-cre)1Wdr/J from IMSR.
View all literature mentionsMus musculus with name B6;129S-Sox2tm1(cre/ERT2)Hoch/J from IMSR.
View all literature mentions